Kalaris Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	34.43	98.05	1.64	90.12	106.09	201.66
Short-Term Investments	62.79	19.93	-	93.82	127.7	46.46
Cash & Short-Term Investments	97.22	117.98	1.64	183.94	233.8	248.12
Cash Growth	-3.71%	7098.41%	-99.11%	-21.32%	-5.77%	-30.37%
Other Receivables	-	-	-	0.21	0.16	0.05
Total Trade Receivables	-	-	-	0.21	0.16	0.05
Other Current Assets	1.25	0.83	0.97	3.49	9.1	5.18
Total Current Assets	98.47	118.81	2.61	187.64	243.05	253.35
Net Property, Plant & Equipment	1.43	1.48	-	2.19	32.56	31.29
Long-Term Investments	7.65	-	-	-	-	-
Other Long-Term Assets	2.25	1.45	0.41	0.97	1.46	1.95
Total Assets	109.81	121.74	6.16	190.8	277.08	286.59
Accounts Payable	0.91	1.28	1.56	6.76	3	8.36
Accrued Expenses	-	-	-	10.09	13.99	20.15
Short-Term Debt	-	-	19.54	-	-	-
Current Portion of Leases	0.32	0.32	-	10.78	7.17	6.59
Other Current Liabilities	-	-	1.41	0.74	0.18	2.75
Total Current Liabilities	8.08	9.71	24.7	28.37	24.34	37.85
Long-Term Debt	32.08	32.08	32.08	-	-	-
Long-Term Leases	1.09	1.13	-	16.65	28.22	23.48
Total Long-Term Liabilities	33.17	33.21	32.08	16.65	28.22	23.48
Total Liabilities	41.25	42.92	56.78	45.02	52.56	61.33
Common Stock	0	0	-	-	0.01	0.01
Additional Paid-in Capital	239.46	238.81	19.95	802.04	690.75	522.48
Accumulated Other Comprehensive Income	-0.05	0.01	-	-0.06	-0.47	-0.16
Retained Earnings	-170.86	-160	-116.56	-656.19	-465.78	-297.07
Total Common Shareholders' Equity	68.56	78.81	-96.62	145.78	224.52	225.27
Minority Interest	-	-	46	-	-	-
Shareholders' Equity	68.56	78.81	-50.62	145.78	224.52	225.27
Total Liabilities & Equity	109.81	121.74	6.16	190.8	277.08	286.59
Total Debt	33.49	33.52	51.62	27.43	35.39	30.07
Net Cash (Debt)	63.73	84.46	-49.98	156.51	198.41	218.05
Net Cash Growth	-24.54%	-	-	-21.12%	-9.01%	-37.27%
Net Cash Per Share	3.16	5.53	-3.27	34.59	59.53	79.88
Book Value	68.56	78.81	-96.62	145.78	224.52	225.27
Book Value Per Share	3.40	5.16	-6.33	32.22	67.37	82.53
Tangible Book Value	68.56	78.81	-96.62	145.78	224.52	225.27
Tangible Book Value Per Share	3.40	5.16	-6.33	32.22	67.37	82.53

Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q